184 related articles for article (PubMed ID: 16411401)
1. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J
Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908
[TBL] [Abstract][Full Text] [Related]
3. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
4. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
5. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical tranexamic acid in open heart surgery.
Abul-Azm A; Abdullah KM
Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the pro-thrombotic state in CAPD patients.
Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
[TBL] [Abstract][Full Text] [Related]
8. Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
Asero R; Tedeschi A; Cugno M
Int Arch Allergy Immunol; 2010; 152(4):384-9. PubMed ID: 20203527
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
[TBL] [Abstract][Full Text] [Related]
10. [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty].
Zhang F; Gao Z; Yu J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1302-4. PubMed ID: 18277670
[TBL] [Abstract][Full Text] [Related]
11. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
Varela Crespo CA; Sanabria Carretero P; Palomero Rodríguez MA; Tormo las de Heras C; Rodríguez Pérez E; Goldman Tarlousky L
Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653
[TBL] [Abstract][Full Text] [Related]
12. Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
Yamamoto J; Yamashita T; Ikarugi H; Taka T; Hashimoto M; Ishii H; Watanabe S; Kovacs IB
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):31-9. PubMed ID: 12544726
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
14. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid decreases the magnitude of platelet dysfunction in aspirin-free patients undergoing cardiac surgery with cardiopulmonary bypass: a pilot study.
Van Aelbrouck C; Jorquera-Vasquez S; Beukinga I; Pradier O; Ickx B; Barvais L; Van Obbergh L; Faraoni D
Blood Coagul Fibrinolysis; 2016 Dec; 27(8):855-861. PubMed ID: 27388281
[TBL] [Abstract][Full Text] [Related]
16. [The influence of recombinant human erythropoietin on platelet phospholipid fatty acid composition in patients on long term hemodialysis].
Krawczyk W; Dmoszyńska A; Ledwozyw A
Pol Merkur Lekarski; 1996 Dec; 1(6):394-7. PubMed ID: 9273229
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human erythropoietin (EPOCH) on the coagulation and fibrinolytic systems and platelet function in pre-dialysis patients with chronic renal failure.
Kaizu K; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):989-97. PubMed ID: 8255011
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
Shapiro F; Zurakowski D; Sethna NF
Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]